David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Liberty Global Class C
LBTYK
|
+$404M |
| 2 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$361M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$327M |
| 4 |
Procter & Gamble
PG
|
+$313M |
| 5 |
Netflix
NFLX
|
+$286M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$453M |
| 2 |
Bank of America
BAC
|
+$405M |
| 3 |
LIFE
LIFE TECHNOLOGIES CORP COM STK (DE)
LIFE
|
+$236M |
| 4 |
Citigroup
C
|
+$219M |
| 5 |
SLB Ltd
SLB
|
+$184M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 9.3% |
| 2 | Healthcare | 8.21% |
| 3 | Consumer Discretionary | 8.05% |
| 4 | Energy | 7.7% |
| 5 | Technology | 7.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MRSH
376
Marsh
MRSH
$91.6B
| $38.3M | 0.05% |
777,751
+496,662
| +177% | +$23.8M |
|
377
Archrock
AROC
$5.58B
| $38.2M | 0.05% |
871,249
+656,752
| +306% | +$24.5M |
|
378
AerCap
AER
$23B
| $38.1M | 0.05% |
902,748
+506,854
| +128% | +$19.8M |
|
379
Crown Castle
CCI
$32.1B
| $38M | 0.05% |
515,682
+427,019
| +482% | +$31.3M |
|
|
STRZA
380
DELISTED
Starz - Series A
STRZA
| $38M | 0.05% |
1,176,566
+285,890
| +32% | +$8.69M |
|
381
Xylem
XYL
$26.5B
| $38M | 0.05% |
1,042,123
+206,687
| +25% | +$7.54M |
|
382
PBF Energy
PBF
$8.72B
| $37.8M | 0.05% |
1,466,088
+213,591
| +17% | +$5.68M |
|
383
Crown Holdings
CCK
$13B
| $37.6M | 0.05% |
840,521
-675,415
| -45% | -$29.3M |
|
384
PUT
McDonald's
MCD
$192B
| $37.5M | 0.05% |
382,800
-347,900
| -48% | -$33.3M |
|
385
Emerson Electric
EMR
$87.7B
| $37.4M | 0.05% |
560,410
+204,251
| +57% | +$13.4M |
|
|
AXLL
386
DELISTED
AXIALL CORP COM STK (DE)
AXLL
| $37.3M | 0.05% |
829,347
-265,514
| -24% | -$11.3M |
|
387
CALL
Regeneron Pharmaceuticals
REGN
$85.9B
| $37.1M | 0.05% |
123,500
-30,500
| -20% | -$9.4M |
|
388
CALL
General Motors
GM
$77.2B
| $36.9M | 0.05% |
1,071,900
-315,300
| -23% | -$11.6M |
|
389
PUT
Capri Holdings
CPRI
$1.55B
| $36.7M | 0.05% |
393,400
+120,000
| +44% | +$10.8M |
|
390
PUT
Intuitive Surgical
ISRG
$134B
| $36.6M | 0.05% |
751,500
-595,800
| -44% | -$28.1M |
|
391
United Parcel Service
UPS
$86.8B
| $36.5M | 0.05% |
374,377
+26,588
| +8% | +$2.59M |
|
392
CALL
Blackrock
BLK
$179B
| $36.4M | 0.05% |
115,600
| – | – |
|
393
CALL
Gilead Sciences
GILD
$181B
| $36.3M | 0.05% |
512,800
-110,000
| -18% | -$8.63M |
|
|
IHS
394
DELISTED
IHS INC CL-A COM STK
IHS
| $36.3M | 0.05% |
298,579
+51,000
| +21% | +$6.02M |
|
395
Jefferies Financial Group
JEF
$12.1B
| $36M | 0.05% |
1,437,466
-357,783
| -20% | -$8.83M |
|
|
CLVS
396
DELISTED
Clovis Oncology, Inc.
CLVS
| $36M | 0.05% |
519,385
-82,028
| -14% | -$6.02M |
|
397
Zimmer Biomet
ZBH
$19.3B
| $35.9M | 0.05% |
390,629
+379,711
| +3,478% | +$35M |
|
|
SINA
398
PUT
DELISTED
Sina Corp
SINA
| $35.9M | 0.05% |
593,500
-233,600
| -28% | -$16.7M |
|
399
CALL
Comcast
CMCSA
$95.3B
| $35.8M | 0.05% |
1,430,400
+560,000
| +64% | +$14.6M |
|
|
SWY
400
DELISTED
SAFEWAY INC
SWY
| $35.5M | 0.05% |
1,073,616
+849,826
| +380% | +$26.4M |
|
Similar funds
David Shaw's Q1 2014 Portfolio in Review
As of Q1 2014, David Shaw held 5,020 positions worth $70.1B, down 4.4% from $73.3B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
David Shaw withdrew a net $4.59B in Q1 2014, closing 795 positions and reducing 1,925 holdings. Its most notable exit was LIFE TECHNOLOGIES CORP COM STK (DE), an estimated $236M position sold in full.
By sector, the portfolio is most concentrated in Communication Services at 9.3% of assets, up from 6.6% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, David Shaw opened a new position in Veren worth $53.3M.
- David Shaw's largest Q1 2014 buy was Veren: 1,596,878 shares worth $53.3M.
- David Shaw added most to Liberty Global Class C in Q1 2014, an estimated $404M increase.
- David Shaw's biggest Q1 2014 reduction was Apple, cutting an estimated $453M.
- David Shaw fully exited LIFE TECHNOLOGIES CORP COM STK (DE) in Q1 2014, selling an estimated $236M.
- David Shaw's ten largest holdings make up 10% of its $70.1B portfolio in Q1 2014.
- David Shaw opened 596 new positions and closed 795 in Q1 2014.
- David Shaw's portfolio value fell 4.4% quarter-over-quarter to $70.1B.
Based on D.E. Shaw & Co's 13F filing for Q1 2014, filed 15 May 2014.